Acute Liver Failure: Mechanisms of Hepatocyte Injury and Regeneration

 

 Buy Article Permissions and Reprints

ABSTRACT

Acute liver failure (ALF) occurs when the extent of hepatocyte death exceeds the liver's regenerative capacity. Despite vast differences in causes, the mode of cell death typically follows one of two patterns: necrosis or apoptosis. Necrosis and apoptosis have traditionally been considered separate entities within various etiologies of ALF; however, there is increasing evidence that they are alternative outcomes of the same initiating factors and signaling pathways, a process known as necroapoptosis. Here we review mechanisms of liver cell injury in ALF, including evolving knowledge of pathways leading to apoptosis, necrosis, and necroapoptosis, as well as how these pathways are potential therapeutic targets in ALF. We also discuss hepatic regeneration and the cytokines and growth factors involved in both the replication of differentiated hepatocytes as well as activation of intrahepatic progenitor cells, two pathways of hepatocyte regeneration that are dependent on the type and extent of hepatic insult in ALF.

REFERENCES

• 1 Kaplowitz N. Mechanisms of liver cell injury.  J Hepatol. 2000;  32 39-47
  PubMedGoogle Scholar
• 2 Kerr J F, Wyllie A H, Currie A R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.  Br J Cancer. 1972;  26 239-257
  CrossrefPubMedGoogle Scholar
• 3 Riordan S M, Williams R. Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure.  Semin Liver Dis. 2003;  23 203-215
  Article in Thieme ConnectPubMedGoogle Scholar
• 4 Gujral J S, Knight T R, Farhood A, Bajt M L, Jaeschke H. Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis?.  Toxicol Sci. 2002;  67 322-328
  CrossrefPubMedGoogle Scholar
• 5 Kass G E, Macanas-Pirard P, Lee P C, Hinton R H. The role of apoptosis in acetaminophen-induced injury.  Ann N Y Acad Sci. 2003;  1010 557-559
  CrossrefPubMedGoogle Scholar
• 6 El-Hassan H, Anwar K, Macanas-Pirard P et al.. Involvement of mitochondria in acetaminophen-induced apoptosis and hepatic injury: roles of cytochrome c, Bax, Bid, and caspases.  Toxicol Appl Pharmacol. 2003;  191 118-129
  CrossrefPubMedGoogle Scholar
• 7 Kim J S, He L, Lemasters J J. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis.  Biochem Biophys Res Commun. 2003;  304 463-470
  CrossrefPubMedGoogle Scholar
• 8 Nicotera P, Leist M, Ferrando-May E. Intracellular ATP, a switch in the decision between apoptosis and necrosis.  Toxicol Lett. 1998;  102-103 139-142
  CrossrefPubMedGoogle Scholar
• 9 Gores G J, Herman B, Lemasters J J. Plasma membrane bleb formation and rupture: a common feature of hepatocellular injury.  Hepatology. 1990;  11 690-698
  CrossrefPubMedGoogle Scholar
• 10 Rosser B G, Gores G J. Liver cell necrosis: cellular mechanisms and clinical implications.  Gastroenterology. 1995;  108 252-275
  PubMedGoogle Scholar
• 11 Jaeschke H, Lemasters J J. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.  Gastroenterology. 2003;  125 1246-1257
  CrossrefPubMedGoogle Scholar
• 12 Kim J S, Qian T, Lemasters J J. Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes.  Gastroenterology. 2003;  124 494-503
  CrossrefPubMedGoogle Scholar
• 13 Gujral J S, Bucci T J, Farhood A, Jaeschke H. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis?.  Hepatology. 2001;  33 397-405
  CrossrefPubMedGoogle Scholar
• 14 Lemasters J J. Dying a thousand deaths: redundant pathways from different organelles to apoptosis and necrosis.  Gastroenterology. 2005;  129 351-360
  CrossrefPubMedGoogle Scholar
• 15 Sodeman T, Bronk S F, Roberts P J, Miyoshi H, Gores G J. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas.  Am J Physiol Gastrointest Liver Physiol. 2000;  278 G992-G999
  PubMedGoogle Scholar
• 16 Galle P R, Hofmann W J, Walczak H et al.. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.  J Exp Med. 1995;  182 1223-1230
  CrossrefPubMedGoogle Scholar
• 17 Lacronique V, Mignon A, Fabre M et al.. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice.  Nat Med. 1996;  2 80-86
  PubMedGoogle Scholar
• 18 Ryo K, Kamogawa Y, Ikeda I et al.. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure.  Am J Gastroenterol. 2000;  95 2047-2055
  CrossrefPubMedGoogle Scholar
• 19 Strand S, Hofmann W J, Grambihler A et al.. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas)-mediated apoptosis.  Nat Med. 1998;  4 588-593
  CrossrefPubMedGoogle Scholar
• 20 Strand S, Strand D, Seufert R et al.. Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome.  Gastroenterology. 2004;  126 849-858
  CrossrefPubMedGoogle Scholar
• 21 Tagami A, Ohnishi H, Moriwaki H, Phillips M, Hughes R D. Fas-mediated apoptosis in acute alcoholic hepatitis.  Hepatogastroenterology. 2003;  50 443-448
  PubMedGoogle Scholar
• 22 Tagami A, Ohnishi H, Hughes R D. Increased serum soluble Fas in patients with acute liver failure due to paracetamol overdose.  Hepatogastroenterology. 2003;  50 742-745
  PubMedGoogle Scholar
• 23 Rutherford A E, Hynan L S, Borges C B et al.. Serum apoptosis markers in acute liver failure: a pilot study.  Clin Gastroenterol Hepatol. 2007;  5 1477-1483
  CrossrefPubMedGoogle Scholar
• 24 Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor.  Biochem Biophys Res Commun. 1998;  244 683-690
  CrossrefPubMedGoogle Scholar
• 25 Bajt M L, Lawson J A, Vonderfecht S L, Gujral J S, Jaeschke H. Protection against Fas receptor-mediated apoptosis in hepatocytes and nonparenchymal cells by a caspase-8 inhibitor in vivo: evidence for a postmitochondrial processing of caspase-8.  Toxicol Sci. 2000;  58 109-117
  CrossrefPubMedGoogle Scholar
• 26 Reinhard C, Shamoon B, Shyamala V, Williams L T. Tumor necrosis factor-alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.  EMBO J. 1997;  16 1080-1092
  CrossrefPubMedGoogle Scholar
• 27 Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNF-alpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases.  Cell. 2005;  120 649-661
  CrossrefPubMedGoogle Scholar
• 28 Streetz K, Leifeld L, Grundmann D et al.. Tumor necrosis factor-alpha in the pathogenesis of human and murine fulminant hepatic failure.  Gastroenterology. 2000;  119 446-460
  PubMedGoogle Scholar
• 29 Rudiger H A, Clavien P A. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver.  Gastroenterology. 2002;  122 202-210
  PubMedGoogle Scholar
• 30 Spahr L, Giostra E, Frossard J L, Bresson-Hadni S, Rubbia-Brandt L, Hadengue A. Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis.  J Hepatol. 2004;  41 229-234
  CrossrefPubMedGoogle Scholar
• 31 Mundt B, Kuhnel F, Zender L et al.. Involvement of TRAIL and its receptors in viral hepatitis.  FASEB J. 2003;  17 94-96
  PubMedGoogle Scholar
• 32 Mundt B, Wirth T, Zender L et al.. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake.  Gut. 2005;  54 1590-1596
  CrossrefPubMedGoogle Scholar
• 33 Hao C, Song J H, Hsi B et al.. TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice.  Cancer Res. 2004;  64 8502-8506
  CrossrefPubMedGoogle Scholar
• 34 Richter C, Schweizer M, Cossarizza A, Franceschi C. Control of apoptosis by the cellular ATP level.  FEBS Lett. 1996;  378 107-110
  CrossrefPubMedGoogle Scholar
• 35 Gasbarrini A, Rapaccini G L, Rutella S et al.. Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis.  Dig Liver Dis. 2007;  39 878-882
  CrossrefPubMedGoogle Scholar
• 36 Kon K, Kim J S, Jaeschke H, Lemasters J J. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes.  Hepatology. 2004;  40 1170-1179
  CrossrefPubMedGoogle Scholar
• 37 Kon K, Ikejima K, Okumura K et al.. Role of apoptosis in acetaminophen hepatotoxicity.  J Gastroenterol Hepatol. 2007;  22(suppl 1) S49-S52
  CrossrefPubMedGoogle Scholar
• 38 Becker E P, Sun D, Minuk G Y. Exogenous adenosine 5′-triphosphate does not improve survival in rats with acute liver failure.  Dig Dis Sci. 2007;  , October 13 (Epub ahead of print)
  PubMedGoogle Scholar
• 39 Kim K M, Kim Y M, Park M et al.. A broad-spectrum caspase inhibitor blocks concanavalin A-induced hepatitis in mice.  Clin Immunol. 2000;  97 221-233
  CrossrefPubMedGoogle Scholar
• 40 Yoshida N, Iwata H, Yamada T et al.. Improvement of the survival rate after rat massive hepatectomy due to the reduction of apoptosis by caspase inhibitor.  J Gastroenterol Hepatol. 2007;  22 2015-2021
  CrossrefPubMedGoogle Scholar
• 41 Chu H C, Lin Y L, Sytwu H K, Lin S H, Liao C L, Chao Y C. Effects of minocycline on Fas-mediated fulminant hepatitis in mice.  Br J Pharmacol. 2005;  144 275-282
  CrossrefPubMedGoogle Scholar
• 42 Kosai K, Matsumoto K, Funakoshi H, Nakamura T. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice.  Hepatology. 1999;  30 151-159
  CrossrefPubMedGoogle Scholar
• 43 Cazanave S, Berson A, Haouzi D et al.. High hepatic glutathione stores alleviate Fas-induced apoptosis in mice.  J Hepatol. 2007;  46 858-868
  CrossrefPubMedGoogle Scholar
• 44 Lee W M, Rossaro L, Fontana R J et al.. Intravenous N-acetylcysteine improves spontaneous survival in early stage non-acetaminophen acute liver failure.  Hepatology. 2007;  46 (suppl) 268A
  PubMedGoogle Scholar
• 45 Fausto N, Campbell J S, Riehle K J. Liver regeneration.  Hepatology. 2006;  43 S45-S53
  CrossrefPubMedGoogle Scholar
• 46 Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells.  Hepatology. 2004;  39 1477-1487
  CrossrefPubMedGoogle Scholar
• 47 Dahlke M H, Popp F C, Bahlmann F H et al.. Liver regeneration in a retrorsine/CCl4-induced acute liver failure model: do bone marrow-derived cells contribute?.  J Hepatol. 2003;  39 365-373
  CrossrefPubMedGoogle Scholar
• 48 Di Campli C, Piscaglia A C, Giuliante F et al.. No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute-on-chronic liver failure.  Transplant Proc. 2005;  37 2563-2566
  CrossrefPubMedGoogle Scholar
• 49 Liu Z C, Chang T M. Transplantation of bioencapsulated bone marrow stem cells improves hepatic regeneration and survival of 90% hepatectomized rats: a preliminary report.  Artif Cells Blood Substit Immobil Biotechnol. 2005;  33 405-410
  PubMedGoogle Scholar
• 50 Okumoto K, Saito T, Onodera M et al.. Serum levels of stem cell factor and thrombopoietin are markedly decreased in fulminant hepatic failure patients with a poor prognosis.  J Gastroenterol Hepatol. 2007;  22 1265-1270
  CrossrefPubMedGoogle Scholar
• 51 Webber E M, Bruix J, Pierce R H, Fausto N. Tumor necrosis factor primes hepatocytes for DNA replication in the rat.  Hepatology. 1998;  28 1226-1234
  CrossrefPubMedGoogle Scholar
• 52 Argast G M, Campbell J S, Brooling J T, Fausto N. Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication.  J Biol Chem. 2004;  279 34530-34536
  CrossrefPubMedGoogle Scholar
• 53 Hecht N, Pappo O, Shouval D, Rose-John S, Galun E, Axelrod J H. Hyper-IL-6 gene therapy reverses fulminant hepatic failure.  Mol Ther. 2001;  3 683-687
  CrossrefPubMedGoogle Scholar
• 54 Aw M M, Mitry R R, Hughes R D, Dhawan A. Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure.  J Pediatr Gastroenterol Nutr. 2007;  44 224-227
  PubMedGoogle Scholar
• 55 Eguchi S, Yanaga K, Okudaira S et al.. Changes in serum levels of hepatocyte growth factor in patients undergoing adult-to-adult living-donor liver transplantation.  Transplantation. 2003;  76 1769-1770
  CrossrefPubMedGoogle Scholar
• 56 Lowes K N, Croager E J, Olynyk J K, Abraham L J, Yeoh G C. Oval cell-mediated liver regeneration: role of cytokines and growth factors.  J Gastroenterol Hepatol. 2003;  18 4-12
  CrossrefPubMedGoogle Scholar
• 57 Nguyen L N, Furuya M H, Wolfraim L A et al.. Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation.  Hepatology. 2007;  45 31-41
  CrossrefPubMedGoogle Scholar
• 58 Brooling J T, Campbell J S, Mitchell C, Yeoh G C, Fausto N. Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma.  Hepatology. 2005;  41 906-915
  CrossrefPubMedGoogle Scholar
• 59 Katoonizadeh A, Nevens F, Verslype C, Pirenne J, Roskams T. Liver regeneration in acute severe liver impairment: a clinicopathological correlation study.  Liver Int. 2006;  26 1225-1233
  CrossrefPubMedGoogle Scholar
• 60 Quiros-Tejeira R E, Molina R A, Katzir L et al.. Resolution of hypophosphatemia is associated with recovery of hepatic function in children with fulminant hepatic failure.  Transpl Int. 2005;  18 1061-1066
  CrossrefPubMedGoogle Scholar
• 61 Schmidt L E, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity.  Hepatology. 2002;  36 659-665
  CrossrefPubMedGoogle Scholar
• 62 Donahower B, McCullough S S, Kurten R et al.. Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity.  Am J Physiol Gastrointest Liver Physiol. 2006;  291 G102-G109
  CrossrefPubMedGoogle Scholar
• 63 Marino G, Piazzese E, Gruttadauria S et al.. New model of liver regeneration induced through use of vascular endothelial growth factor.  Transplant Proc. 2006;  38 1193-1194
  CrossrefPubMedGoogle Scholar
• 64 Namisaki T, Yoshiji H, Kojima H et al.. Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats.  J Hepatol. 2006;  44 568-575
  CrossrefPubMedGoogle Scholar
• 65 Malik R, Saich R, Rahman T, Hodgson H. During thioacetamide-induced acute liver failure, the proliferative response of hepatocytes to thyroid hormone is maintained, indicating a potential therapeutic approach to toxin-induced liver disease.  Dig Dis Sci. 2006;  51 2235-2241
  CrossrefPubMedGoogle Scholar
• 66 Oren R, Resnick M B, Brill S et al.. Thyroxine accelerates proliferation of injured liver cells.  J Hepatol. 1998;  29 634-637
  CrossrefPubMedGoogle Scholar
• 67 Lesurtel M, Graf R, Aleil B et al.. Platelet-derived serotonin mediates liver regeneration.  Science. 2006;  312 104-107
  CrossrefPubMedGoogle Scholar
• 68 Papadimas G K, Tzirogiannis K N, Panoutsopoulos G I et al.. Effect of serotonin receptor 2 blockage on liver regeneration after partial hepatectomy in the rat liver.  Liver Int. 2006;  26 352-361
  CrossrefPubMedGoogle Scholar

Anna RutherfordM.D. M.P.H. 

Staff Physician, Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital

75 Francis Street, Boston, MA 02115

Email: ARutherford@partners.org